About
Samsara Vision is a specialty medical device company based in Far Hills, New Jersey, focused on developing and marketing implantable ophthalmic devices. Founded in 1997, the company aims to enhance vision and quality of life for patients with late-stage retinal disorders, particularly Age-Related Macular Degeneration (AMD). Their flagship product, the Implantable Miniature Telescope (IMT), received FDA approval in 2010 and a CE Mark in 2005. The company has also introduced the Smaller-Incision New Generation (SING) IMT and a Tsert delivery system, both of which are CE Mark certified and began commercialization in Europe in 2021. Samsara Vision is dedicated to research and development of next-generation devices and offers a comprehensive patient support program to assist healthcare providers in treating visually impaired patients. With a team of around 20 employees, Samsara Vision collaborates with healthcare providers, researchers, and patient advocates to ensure access to their innovative technologies. The company is led by CEO Thomas Ruggia.
Technologies
Keywords
Company Information
-
Employees 42
-
Founded 1997
-
Total Funding $79541669
Location
27 US-202, Far Hills, New Jersey, United States, 07931-7001